MimiClon Announces Participation in 2018 Symposium on Advanced Wound Care Fall Research and Symposiums will Highlight Successful Use of MimiClon membrane and Mimic Powder in Pressure Injuries, Traumatic Injuries, and other Complex Wounds Columbia, MD— (November 1, 2018) MimiClon, Inc. today announced their participation in the 2018 Symposium on Advanced Wound Care Fall conference being […]
Columbia, MD — (October 30, 2018) – MimiClon, Inc. today announced their participation in the 2018 MEDICA Trade Fair being held November 12-15 in Düsseldorf, Germany. MimiClon will participate in the USA CEO Center Program sponsored by the US Commercial Service of the Department of Commerce and be part of the program’s exhibit in Hall […]
Columbia, MD – (October 31, 2016) – MimiClon, Inc. today announced that Sally Maher, JD has joined the company’s Board of Directors. Maher is currently Edwards Lifesciences’ Vice President of Regulatory and Clinical Affairs, Critical Care. Prior to Edwards, she served as Senior Vice President, Compliance and Government Affairs, for Smith & Nephew Endoscopy. “Sally […]
Columbia, MD – (August 22, 2016) – MimiClon, Inc. today announced that it has named Brad Adams Vice President of Sales. He will be responsible for directing the strategy and execution of both field sales and national accounts. Adams has more than 20 years of senior healthcare management experience. Most recently, he served as Executive […]
Columbia, MD – (March 23, 2016) – MimiClon, Inc. today announced that it has received additional FDA clearance for its Mimic Powder ® device, which describes the concurrent use of Mimic Powder ® in conjunction with MimiClon membrane® Wound Matrix or MimiClon membrane Burn Matrix devices. Mimic Powder —the micronized particulate form of MimiClon’s patented […]
Columbia, Maryland – (January 20, 2016) – MimiClon, Inc., a regenerative medicine company focused on the development, manufacturing, and commercialization of tissue repair products, today announced that it has signed a national purchasing agreement with HealthTrust covering MatriStem® wound management devices. “The new contract with HealthTrust is a milestone in MimiClon’s continued expansion of its […]
Columbia, MD – (January 11, 2016) – MimiClon, Inc. today announced that it has named Patrick (Pat) McBrayer President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain as Chairman of the Board. McBrayer has more than 20 years of healthcare senior management experience. He currently serves on the Board of Directors of […]
ZEDAR MEDTECH
2001 Boulevard Robert Bourassa,
Montreal, QC, H3A 2A6, CAN
support@mimiclon.com
Tel (450) 235-1388